During the past decade, Chelyabinsk Regional Clinical Hospital conducted 33 clinical trials. In the 10-year time frame, 33 clinical trials started and 12 clinical trials were completed, i.e. on average, 36.4% percent of trials that started reached the finish line to date. In the past 5 years, 13 clinical trials started and 9 clinical trials were completed. i.e. 69.2% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Chelyabinsk Regional Clinical Hospital" #1 sponsor was "Biocad" with 5 trials, followed by "AO GENERIUM" with 3 trials sponsored, "Celgene" with 3 trials sponsored, "Takeda" with 3 trials sponsored and "Actelion" with 3 trials sponsored. Other sponsors include 17 different institutions and companies that sponsored additional 21 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Chelyabinsk Regional Clinical Hospital" #1 collaborator was "ADIR, a Servier Group company" with 2 trials as a collaborator, "Gilead Sciences" with 2 trials as a collaborator, "Incyte Corporation" with 2 trials as a collaborator, "Les Laboratoires Servier (L.L.S), Russia" with 2 trials as a collaborator and "A.O.U. Città della Salute e della Scienza - Molinette Hospital" with 1 trials as a collaborator. Other collaborators include 93 different institutions and companies that were collaborators in the rest 103 trials.

According to Clinical.Site data, the most researched conditions in "Chelyabinsk Regional Clinical Hospital" are "Crohn Disease" (4 trials), "Rheumatoid Arthritis" (4 trials), "Systemic Lupus Erythematosus" (3 trials), "Acute Lymphoblastic Leukemia" (2 trials) and "Ankylosing Spondylitis" (2 trials). Many other conditions were trialed in "Chelyabinsk Regional Clinical Hospital" in a lesser frequency.

Most popular intervention types in "Chelyabinsk Regional Clinical Hospital" are "Drug" (31 trials), "Biological" (4 trials), "Other" (4 trials) and "Radiation" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (14 trials), "Filgotinib" (3 trials), "Ozanimod" (3 trials), "BCD-085" (2 trials) and "Baricitinib" (2 trials). Other intervention names were less common.

The vast majority of trials in "Chelyabinsk Regional Clinical Hospital" are 36 trials for "All" genders, 1 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Chelyabinsk Regional Clinical Hospital". undefined are not yet recruiting, 7 are recruiting, 7 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 18 completed trials in Chelyabinsk Regional Clinical Hospital, undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in Chelyabinsk Regional Clinical Hospital, 1 "Phase 1" clinical trials were conducted, 11 "Phase 2" clinical trials and 19 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".